Results 251 to 260 of about 81,130 (269)
Some of the next articles are maybe not open access.

Erythema Chronicum Migrans Afzelius in Americans

Archives of Dermatology, 1962
Erythema chronicum migrans Afzelius is frequently diagnosed in Northern European patients, but as Baer and Witten 1 pointed out recently, is seldom seen in Americans. The purpose of this paper is to report a case seen at the USAF Hospital Wiesbaden (Germany) in an American stationed in Europe.
openaire   +3 more sources

Treatment failure in erythema migrans — a review

Infection, 1996
Patients with erythema migrans can fail to respond to antibiotic therapy. Persistent or recurrent erythema migrans, major sequelae such as meningitis and arthritis, survival of Borrelia burgdorferi and significant and persistent increase of antibody titres against B.
openaire   +3 more sources

Automated detection of erythema migrans and other confounding skin lesions via deep learning

Comput. Biol. Medicine, 2019
P. Burlina   +5 more
semanticscholar   +1 more source

Evaluation of Prospectively Followed Adult Patients with Erythema Migrans Using the Beck Depression Inventory Second Edition.

American Journal of Medicine, 2019
G. Wormser   +8 more
semanticscholar   +1 more source

Skin Image Analysis for Erythema Migrans Detection and Automated Lyme Disease Referral

OR 2.0/CARE/CLIP/ISIC@MICCAI, 2018
P. Burlina   +5 more
semanticscholar   +1 more source

Erythema migrans

Clinics in Dermatology, 1993
openaire   +2 more sources

Efficacy of a 14-day course of amoxicillin for patients with erythema migrans.

Diagnostic microbiology and infectious disease, 2019
G. Wormser   +4 more
semanticscholar   +1 more source

Erythema chronicum migrans.

The Journal of the American Osteopathic Association, 2012
Vicki L. Jacobsen   +2 more
openaire   +3 more sources

Candidatus Neoehrlichia mikurensis and Borrelia burgdorferi sensu lato detected in the blood of Norwegian patients with erythema migrans.

Ticks and Tick-borne Diseases, 2017
H. Quarsten   +7 more
semanticscholar   +1 more source

Home - About - Disclaimer - Privacy